Timing genomic antigen loss in multiple myeloma treated with T-cell redirecting immunotherapies

Overview of attention for article published in Blood Cancer Discovery, September 2025

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

blogs: 1 blog
twitter: 27 X users

bluesky: 2 Bluesky users

Readers on

mendeley: 5 Mendeley

So far, Altmetric has seen 56 X posts from 27 X users, with an upper bound of 80,586 followers.

Read this research brief by #IMS26 speakers Nizar Bahlis, Holly Lee, Francesco Maura, and Leo Rasche, “Timing Genomic Antigen Loss in Multiple Myeloma Treated with T Cell–Redirecting Immunotherapies.” https://t.co/48B04lFcJ3 @NBahlis @hollyleeYJ @Francesc…

RT @mtmdphd: Timing genomic antigen loss in multiple myeloma treated with T-cell redirecting immunotherapies [Sep 4, 2025] Papadimitriou et…

Timing genomic antigen loss in multiple myeloma treated with T-cell redirecting immunotherapies [Sep 4, 2025] Papadimitriou et al. @FrancescoMaura4 @BCD_AACR https://t.co/orPSZiecRS #mmsm #CARTcell #PrecisionMedicine #WGS THREAD: https://t.co/qnjshSXw9e…

RT @FrancescoMaura4: here the link to the paper: https://t.co/f1vY86EaqT

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 52 additional X posts.